 |
|
|
| |
Safety and tolerability of extended (96 weeks) treatment with peginterferon alfa-2a [40KD] in genotype D patients with HBeAg-negative chronic hepatitis B
|
| |
| |
Reported by Jules Levin
61st AASLD Nov 2 2010 Boston
P Lampertico, M Vigano, GG Di Costanzo, E Sagnelli, M Fasano,
V Di Marco, S Boninsegna, P Farci, S Fargion, T Giuberti,
C Iannacone, B Massetto, EB Martins, M Colombo on behalf of the PegBeLiver Study Group
First Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
|
| |
|
|
|
|
|
